The Science of Phosphatonins: How Your Doctor Diagnoses Tumor-Induced Phosphate Leaks

Phosphatonins are hormones that regulate phosphate balance in your body. The most well-known phosphatonin is Fibroblast Growth Factor 23 (FGF23). Under normal conditions, FGF23 helps prevent phosphate overload by reducing kidney reabsorption of phosphate. However, in rare cases a slow-growing tumor produces excess FGF23, causing continual phosphate loss—an issue called tumor-induced osteomalacia (TIO).

Below, we’ll explore how your doctor uses lab tests (including the Fibroblast growth factor 23 FGF23 blood test), imaging studies, and other tools to diagnose and treat phosphate-leaking tumors.

---

1. Understanding FGF23 and Phosphate Balance

• FGF23 is a hormone produced mainly by bone cells.
• It decreases phosphate reabsorption in the kidney’s proximal tubules, increasing urinary phosphate excretion.
• It suppresses activation of vitamin D (reduces 1,25-dihydroxyvitamin D), lowering intestinal phosphate absorption.

Why balance matters
Phosphate is vital for:

• Energy production (ATP)
• Bone mineralization
• Cell signaling

Too little phosphate can lead to bone pain, muscle weakness, and fractures.

---

2. When Phosphatonins Go Rogue: Tumor-Induced Osteomalacia

In TIO, small mesenchymal tumors secrete excess FGF23 (and sometimes other phosphatonins). The result:

• Chronic hypophosphatemia (low blood phosphate)
• Inappropriately normal or high FGF23 levels despite low phosphate
• Impaired bone mineralization (osteomalacia)

These tumors are often benign and slow-growing but can be hard to locate.

---

3. Recognizing the Signs

Symptoms develop slowly and may include:

• Generalized bone pain and tenderness
• Muscle weakness, especially in the thighs and hips
• Fatigue and difficulty walking
• Stress fractures or spontaneous fractures

Because these signs are non-specific, diagnosis can be delayed. If you have unexplained bone pain or weakness, it’s reasonable to seek evaluation—and consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.

---

4. Initial Laboratory Evaluation

Your doctor starts with basic blood and urine tests:

1. Serum tests

   • Phosphate: low
   • Calcium: normal or low-normal
   • Alkaline phosphatase: high (reflects bone turnover)
   • 25-hydroxyvitamin D: to rule out deficiency
   • Parathyroid hormone (PTH): usually normal

2. Urine tests

   • 24-hour urine phosphate: elevated
   • Calculation of tubular maximum reabsorption of phosphate per glomerular filtration rate (TmP/GFR): decreased

3. FGF23 blood test

   • Measures intact FGF23 levels
   • In TIO, FGF23 is inappropriately elevated despite hypophosphatemia

Key point: Low phosphate with high FGF23 is the biochemical hallmark of TIO.

---

5. Advanced Testing: Confirming the Diagnosis

If initial labs suggest TIO, more detailed testing can include:

• 1,25-dihydroxyvitamin D: typically low or inappropriately normal
• Genetic testing (in young patients) to distinguish inherited hypophosphatemic rickets from acquired TIO

Your doctor may repeat the Fibroblast growth factor 23 FGF23 blood test to confirm persistently high levels. Timing matters: FGF23 levels can fluctuate, so multiple measurements strengthen the diagnosis.

---

6. Locating the Culprit: Imaging Studies

Tumors causing TIO are often small and located in bone or soft tissue. Imaging strategies include:

• Functional imaging
– 68Ga-DOTATATE PET/CT: high sensitivity for mesenchymal tumors
– 18F-FDG PET/CT: identifies areas of high metabolic activity
– Octreotide scintigraphy (in select centers)

• Anatomic imaging
– MRI: detailed soft-tissue resolution
– High-resolution CT: small bone lesions

Your doctor chooses studies based on availability and clinical context. It may take a combination of scans to pinpoint the tumor.

---

7. Confirming the Tumor Pathology

Once a suspicious lesion is found:

1. Image-guided biopsy or surgical resection
2. Histopathology confirms a phosphaturic mesenchymal tumor
3. Immunohistochemical staining may demonstrate FGF23 production

Definitive diagnosis allows targeted treatment.

---

8. Treatment and Follow-Up

• Surgical removal
– Complete resection usually cures TIO
– Phosphate levels and FGF23 normalize rapidly

• Medical management (if tumor can’t be found or resected)
– Oral phosphate supplements
– Active vitamin D analogs (e.g., calcitriol)
– Newer agents under investigation that block FGF23 activity

• Monitoring
– Regular serum phosphate and FGF23 blood tests
– Bone density scans to assess recovery of bone mineralization
– Clinical evaluation of symptoms

Most patients experience significant improvement once phosphate homeostasis is restored.

---

9. When to Seek Medical Advice

If you notice persistent muscle weakness, bone pain, or unexplained fractures, don’t wait. Consider:

• Scheduling a primary care appointment
• Using a free, online symptom check, using the doctor approved Ubie Symptom Checker
• Speaking to a doctor about your concerns—early evaluation can prevent complications

---

10. Key Takeaways

• FGF23 is the main phosphatonin regulating phosphate; excess leads to urinary phosphate wasting.
• Tumor-induced osteomalacia is rare but treatable when diagnosed.
• The Fibroblast growth factor 23 FGF23 blood test, together with routine labs (serum phosphate, TmP/GFR), is critical for diagnosis.
• Functional and anatomic imaging localizes the tumor for surgical removal.
• Speak to a doctor if you have ongoing bone symptoms or muscle weakness—timely intervention matters.

---

Disclaimer: This information is for educational purposes and does not replace professional medical advice. If you experience serious or life-threatening symptoms, speak to a doctor right away.